These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20501715)

  • 1. Tumor blood volume determination by using susceptibility-corrected DeltaR2* multiecho MR.
    Persigehl T; Wall A; Kellert J; Ring J; Remmele S; Heindel W; Dahnke H; Bremer C
    Radiology; 2010 Jun; 255(3):781-9. PubMed ID: 20501715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiangiogenic tumor treatment: early noninvasive monitoring with USPIO-enhanced MR imaging in mice.
    Persigehl T; Bieker R; Matuszewski L; Wall A; Kessler T; Kooijman H; Meier N; Ebert W; Berdel WE; Heindel W; Mesters RM; Bremer C
    Radiology; 2007 Aug; 244(2):449-56. PubMed ID: 17562810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of bevacizumab-induced antiangiogenic treatment effects by "steady state" ultrasmall superparamagnetic iron oxide particles magnetic resonance imaging using robust multiecho ΔR2* relaxometry.
    Ring J; Persigehl T; Remmele S; Heindel W; Dahnke H; Bremer C
    Invest Radiol; 2011 May; 46(5):326-30. PubMed ID: 21358548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of bone marrow angiogenesis in patients with acute myeloid leukemia by using contrast-enhanced MR imaging with clinically approved iron oxides: initial experience.
    Matuszewski L; Persigehl T; Wall A; Meier N; Bieker R; Kooijman H; Tombach B; Mesters R; Berdel WE; Heindel W; Bremer C
    Radiology; 2007 Jan; 242(1):217-24. PubMed ID: 17116730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gadopentetate dimeglumine versus ultrasmall superparamagnetic iron oxide for dynamic contrast-enhanced MR imaging of tumor angiogenesis in human colon carcinoma in mice.
    de Lussanet QG; Backes WH; Griffioen AW; van Engelshoven JM; Beets-Tan RG
    Radiology; 2003 Nov; 229(2):429-38. PubMed ID: 14595147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vessel size imaging (VSI) by robust magnetic resonance (MR) relaxometry: MR-VSI of solid tumors in correlation with immunohistology and intravital microscopy.
    Persigehl T; Ring J; Budny T; Hahnenkamp A; Stoeppeler S; Schwartz LH; Spiegel HU; Heindel W; Remmele S; Bremer C
    Mol Imaging; 2013 Oct; 12(7):1-11. PubMed ID: 23962676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of antiangiogenic treatment efficacy by iron oxide enhanced parametric magnetic resonance imaging.
    Persigehl T; Matuszewski L; Kessler T; Wall A; Meier N; Ebert W; Berdel WE; Heindel W; Mesters R; Bremer C
    Invest Radiol; 2007 Dec; 42(12):791-6. PubMed ID: 18007150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparametric characterization of response to anti-angiogenic therapy using USPIO contrast-enhanced MRI in combination with dynamic contrast-enhanced MRI.
    Kim J; Kim E; Euceda LR; Meyer DE; Langseth K; Bathen TF; Moestue SA; Huuse EM
    J Magn Reson Imaging; 2018 Jun; 47(6):1589-1600. PubMed ID: 29205621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic analysis of superparamagnetic iron oxide nanoparticles in the liver of body-temperature-controlled mice using dynamic susceptibility contrast magnetic resonance imaging and an empirical mathematical model.
    Murase K; Assanai P; Takata H; Matsumoto N; Saito S; Nishiura M
    Magn Reson Imaging; 2015 Jun; 33(5):600-10. PubMed ID: 25683514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-enhanced susceptibility weighted imaging with ultrasmall superparamagnetic iron oxide improves the detection of tumor vascularity in a hepatocellular carcinoma nude mouse model.
    Yang SH; Lin J; Lu F; Dai YY; Han ZH; Fu CX; Hu FL; Gu HC
    J Magn Reson Imaging; 2016 Aug; 44(2):288-95. PubMed ID: 26808392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UTE-ΔR2 -ΔR2 * combined MR whole-brain angiogram using dual-contrast superparamagnetic iron oxide nanoparticles.
    Jung HS; Jin SH; Cho JH; Han SH; Lee DK; Cho H
    NMR Biomed; 2016 Jun; 29(6):690-701. PubMed ID: 27061076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive Differentiation between Hepatic Steatosis and Steatohepatitis with MR Imaging Enhanced with USPIOs in Patients with Nonalcoholic Fatty Liver Disease: A Proof-of-Concept Study.
    Smits LP; Coolen BF; Panno MD; Runge JH; Nijhof WH; Verheij J; Nieuwdorp M; Stoker J; Beuers UH; Nederveen AJ; Stroes ES
    Radiology; 2016 Mar; 278(3):782-91. PubMed ID: 26348104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of absolute blood volume in carcinoma by USPIO contrast-enhanced MRI.
    Gambarota G; van Laarhoven HW; Philippens M; Lok J; van der Kogel A; Punt CJ; Heerschap A
    Magn Reson Imaging; 2006 Apr; 24(3):279-86. PubMed ID: 16563957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging of macrophages in soft-tissue infection in rats: relationship between ultrasmall superparamagnetic iron oxide dose and MR signal characteristics.
    Lutz AM; Weishaupt D; Persohn E; Goepfert K; Froehlich J; Sasse B; Gottschalk J; Marincek B; Kaim AH
    Radiology; 2005 Mar; 234(3):765-75. PubMed ID: 15665219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-CXCR4 monoclonal antibody conjugated to ultrasmall superparamagnetic iron oxide nanoparticles in an application of MR molecular imaging of pancreatic cancer cell lines.
    He Y; Song W; Lei J; Li Z; Cao J; Huang S; Meng J; Xu H; Jin Z; Xue H
    Acta Radiol; 2012 Nov; 53(9):1049-58. PubMed ID: 23012484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancers: MR imaging of folate-receptor expression with the folate-specific nanoparticle P1133.
    Meier R; Henning TD; Boddington S; Tavri S; Arora S; Piontek G; Rudelius M; Corot C; Daldrup-Link HE
    Radiology; 2010 May; 255(2):527-35. PubMed ID: 20413763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of fast and ultrafast T2-weighted MR imaging sequences in hepatic enhancement with ferumoxides: comparison with conventional spin-echo sequence.
    Abe Y; Yamashita Y; Namimoto T; Tang Y; Takahashi M
    Radiat Med; 2000; 18(2):97-105. PubMed ID: 10888042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RGD-labeled USPIO inhibits adhesion and endocytotic activity of alpha v beta3-integrin-expressing glioma cells and only accumulates in the vascular tumor compartment.
    Kiessling F; Huppert J; Zhang C; Jayapaul J; Zwick S; Woenne EC; Mueller MM; Zentgraf H; Eisenhut M; Addadi Y; Neeman M; Semmler W
    Radiology; 2009 Nov; 253(2):462-9. PubMed ID: 19789239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. R2 and R2* mapping for sensing cell-bound superparamagnetic nanoparticles: in vitro and murine in vivo testing.
    Kuhlpeter R; Dahnke H; Matuszewski L; Persigehl T; von Wallbrunn A; Allkemper T; Heindel WL; Schaeffter T; Bremer C
    Radiology; 2007 Nov; 245(2):449-57. PubMed ID: 17848680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific targeting of breast tumor by octreotide-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 3.0-Tesla magnetic resonance scanner.
    Li X; Du X; Huo T; Liu X; Zhang S; Yuan F
    Acta Radiol; 2009 Jul; 50(6):583-94. PubMed ID: 19449236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.